(Q46325178)

English

A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Masoumeh Rajabibazl

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Seyed Latif Mousavi Gargari

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Fatemeh Araste

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Walead Ebrahimizadeh

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

26 September 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Biotechnology Letters

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

21-28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

https://scigraph.springernature.com/pub.10.1007/s10529-013-1340-1

0 references

Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

New technologies in therapeutic antibody development

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes.

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

Glucose regulated proteins in cancer progression, drug resistance and immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

Carbonic anhydrase IX as a target for metastatic disease

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

Carbonic anhydrase isozymes in the human pancreas

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

RENCA/carbonic anhydrase-IX: a murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1340-1

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46325178&oldid=1166603876"